Bangladesh’s national tuberculosis program is picking up after a blow dealt by the COVID-19 pandemic, but room for improvement remains

In today’s episode, we look at a verdict from India that will bring relief to patients of drug-resistant TB, the dismissal of workers from a factory in Myanmar and the ban on transgender athletes from participating in women’s events

A day ahead of World TB Day, the Indian Patent Office rejected pharma giant Jannsen’s application for a patent extension on drug bedaquiline. If the patent had been extended, public and family budgets would have remained burdened by unjustifiably high costs of the drug

The West cannot keep infectious diseases out any more than claim victory over them. Microbes evolve and strike back unless sporadic outbreaks are tackled wherever they occur

Today we look at a debt restructuring talks between Argentina and the IMF, a workers’ protest against rising costs and poverty in Turkey, and more

What is the long view of COVID-19 as we have seen and are likely to see going forward? How were various aspects of our life affected by the pandemic, what are the changes we have had to make, and how has the treatment of other diseases been affected?

Treatment and care for TB patients was sidelined in this period of the pandemic causing the number of deaths from to rise again after many years, and years of progress to be reversed